Ardent Health Faces Class Action Over Accounting Practices

BenzingaBenzinga
|||1 min read
Key Takeaway

Ardent Health faces securities class action for allegedly inflating receivables through misleading accounting practices. Class period runs July 2024 through November 2025.

Ardent Health Faces Class Action Over Accounting Practices

Ardent Health, Inc. (NYSE: ARDT) is the subject of a securities class action lawsuit alleging the company made materially false and misleading statements regarding its financial condition. According to the complaint, Ardent utilized a 180-day cliff on accounts receivable to report inflated receivables while deferring the recognition of losses, potentially misrepresenting the company's financial position to investors.

The lawsuit encompasses a class period from July 18, 2024, through November 12, 2025, and covers all shareholders who purchased Ardent securities during this timeframe. Shareholders interested in participating in the litigation must take action by the March 9, 2026 deadline to preserve their rights in the case.

The allegations center on accounting treatment of receivables, a key metric investors use to evaluate a company's operational health and revenue quality. The case remains ongoing, and no determination has been made regarding the merits of the claims.

Source: Benzinga

Back to newsPublished Feb 17

Related Coverage

GlobeNewswire Inc.

Plug Power Faces Class Action Over DOE Loan Claims as April Deadline Looms

Plug Power faces class action lawsuit alleging false statements about DOE loans and hydrogen facilities. Investors have until April 3, 2026 to apply as lead plaintiffs.

PLUG
GlobeNewswire Inc.

BlackRock TCP Capital Hit by Class Action Over $19B NAV Collapse

BlackRock TCP Capital faces class action lawsuit after 19% NAV decline and 12.97% stock plunge. Investors must act by April 6 deadline.

TCPC
GlobeNewswire Inc.

Corcept Therapeutics Faces Class Action Over FDA Rejection; Stock Crashed 50%

Corcept Therapeutics faces securities fraud lawsuit after FDA rejected relacorilant application. Stock plummeted 50.4% following December rejection. Investor deadline April 21, 2026.

CORT
GlobeNewswire Inc.

Class Action Lawsuit Filed Against China Liberal Education Over Alleged $300M Pump-and-Dump Scheme

Class action lawsuit filed against China Liberal Education Holdings for alleged pump-and-dump scheme coordinating with scammers, resulting in $300M+ investor losses.

CLEUF
GlobeNewswire Inc.

METC Faces Class Action Over Brook Mine Claims; Lead Plaintiff Deadline Set for March 31

Ramaco Resources faces class action lawsuit over alleged false Brook Mine operational claims, with lead plaintiff deadline set for March 31, 2026.

METCMETCBMETCI
GlobeNewswire Inc.

Disc Medicine Stock Collapses on FDA Rejection; Law Firm Probes Securities Fraud

Pomerantz LLP investigates Disc Medicine ($IRON) for potential securities fraud after FDA rejected bitopertin drug application, triggering consecutive stock declines totaling over 28%.

IRON